CA2411058C - Traitement cutane a l'aide d'un nouveau retinoide - Google Patents

Traitement cutane a l'aide d'un nouveau retinoide Download PDF

Info

Publication number
CA2411058C
CA2411058C CA002411058A CA2411058A CA2411058C CA 2411058 C CA2411058 C CA 2411058C CA 002411058 A CA002411058 A CA 002411058A CA 2411058 A CA2411058 A CA 2411058A CA 2411058 C CA2411058 C CA 2411058C
Authority
CA
Canada
Prior art keywords
composition
lip
skin
retinoxytrimethylsilane
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002411058A
Other languages
English (en)
Other versions
CA2411058A1 (fr
Inventor
Michele Duggan
Lorraine M. Cowton
John Duffy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avon Products Inc
Original Assignee
Avon Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products Inc filed Critical Avon Products Inc
Publication of CA2411058A1 publication Critical patent/CA2411058A1/fr
Application granted granted Critical
Publication of CA2411058C publication Critical patent/CA2411058C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une composition topique et une méthode pour améliorer l'apparence esthétique de la peau, notamment la prévention, l'amélioration, le traitement et/ou la réduction de ridules et/ou de rides, sans causer d'irritation de la peau généralement associée à l'application topique d'un rétinoïde. L'invention concerne également une composition topique et une méthode pour améliorer l'apparence esthétique des lèvres, notamment pour diminuer le nombre et/ou la profondeur des lignes de lèvre verticales. La composition comprend une quantité efficace de rétinoxytriméthylsilane. De préférence, la composition est appliquée quotidiemment sur la peau et/ou les lèvres. La composition et la méthode conviennent particulièrement aux personnes ayant la peau sensible.
CA002411058A 2001-11-09 2002-10-31 Traitement cutane a l'aide d'un nouveau retinoide Expired - Lifetime CA2411058C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/039,745 2001-11-09
US10/039,745 US6641824B2 (en) 2001-11-09 2001-11-09 Skin treatment using a new retinoid

Publications (2)

Publication Number Publication Date
CA2411058A1 CA2411058A1 (fr) 2003-05-09
CA2411058C true CA2411058C (fr) 2009-12-29

Family

ID=21907136

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002411058A Expired - Lifetime CA2411058C (fr) 2001-11-09 2002-10-31 Traitement cutane a l'aide d'un nouveau retinoide

Country Status (6)

Country Link
US (2) US6641824B2 (fr)
JP (1) JP4454927B2 (fr)
CN (1) CN1264499C (fr)
BR (1) BRPI0204618B1 (fr)
CA (1) CA2411058C (fr)
PL (1) PL219738B1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641824B2 (en) * 2001-11-09 2003-11-04 Avon Products, Inc. Skin treatment using a new retinoid
US20030138467A1 (en) * 2001-12-27 2003-07-24 Avon Products, Inc. Methods for improving the aesthetic appearance of skin
US20040105875A1 (en) * 2002-10-03 2004-06-03 L'oreal Composition containing a secondary or tertiary carbonyl amine, method of use thereof, compounds
CA2546464A1 (fr) * 2005-05-04 2006-11-04 Richard Wachsberg Application sequentielle de formulations orales et topiques pour traiter les rides et autres dommages subis par la peau
US20060280711A1 (en) * 2005-06-14 2006-12-14 L'oreal Process for treating marionette lines
US20090053290A1 (en) * 2006-03-08 2009-02-26 Sand Bruce J Transdermal drug delivery compositions and topical compositions for application on the skin
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10835584B2 (en) 2016-06-17 2020-11-17 Nuvothera, Inc. Systems for treating dermal inflammatory conditions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3006939A (en) 1957-01-17 1961-10-31 Basf Ag Production of compounds of the betacyclogeranylidene series
US3000939A (en) 1957-07-08 1961-09-19 Aerojet General Co N-nitro,n,n'-bis(trinitroalkyl)-urea
US3060229A (en) 1959-12-21 1962-10-23 Bayer Ag Process for the production of vitamin-acompounds
US3932665A (en) 1974-04-05 1976-01-13 Scott Eugene J Van Process for the treatment of acne vulgaris utilizing retinal
DE3372843D1 (en) * 1982-05-15 1987-09-10 Beecham Group Plc Skin treatment compositions
US4826828A (en) 1985-04-22 1989-05-02 Avon Products, Inc. Composition and method for reducing wrinkles
US4804670A (en) 1985-09-03 1989-02-14 Basf Aktiengesellschaft Substituted hexatriene derivatives and their use in treating acne and psoriasis
US4934114A (en) 1986-08-27 1990-06-19 Lindsey Mfg. Co. Lightweight line tower kit
DE4309297C2 (de) * 1993-03-23 1997-11-06 Rhodia Ag Rhone Poulenc Verfahren zur Silylierung von Cellulose und Verwendung der silylierten Cellulose
US5834513A (en) 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5847003A (en) 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
JPH10158290A (ja) * 1996-11-25 1998-06-16 Nisshin Oil Mills Ltd:The レチノール配糖体及びそれを配合してなる化粧料
US5760276A (en) 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US5847179A (en) * 1997-10-02 1998-12-08 Pcr, Inc. High purity alkoxytrimethylsilane fluids
US6143309A (en) * 1998-03-12 2000-11-07 Archimica (Florida), Inc. Delivery of hydroxy carboxylic acids
JPH11302145A (ja) * 1998-04-16 1999-11-02 Hamari Chem Ltd 日やけ止め化粧料
US6166244A (en) 1999-05-07 2000-12-26 Allergan Sales, Inc. Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
JP3661981B2 (ja) * 1999-06-09 2005-06-22 株式会社ノエビア 制汗剤
JP3504551B2 (ja) * 1999-11-22 2004-03-08 株式会社ノエビア 皮膚外用剤
JP4326689B2 (ja) * 1999-12-24 2009-09-09 株式会社資生堂 プラスミノーゲンアクチベーター阻害剤およびそれを配合した皮膚外用剤
US20030044372A1 (en) * 2001-08-30 2003-03-06 Legrow Gary E. Stable aqueous emulsions of alkoxytrimethylsilane fluids
US6641824B2 (en) * 2001-11-09 2003-11-04 Avon Products, Inc. Skin treatment using a new retinoid

Also Published As

Publication number Publication date
CA2411058A1 (fr) 2003-05-09
JP2003183164A (ja) 2003-07-03
US7074420B2 (en) 2006-07-11
PL357033A1 (en) 2003-05-19
PL219738B1 (pl) 2015-07-31
US6641824B2 (en) 2003-11-04
CN1418616A (zh) 2003-05-21
JP4454927B2 (ja) 2010-04-21
BR0204618A (pt) 2003-09-16
US20030092675A1 (en) 2003-05-15
BRPI0204618B1 (pt) 2015-07-14
US20030091607A1 (en) 2003-05-15
CN1264499C (zh) 2006-07-19

Similar Documents

Publication Publication Date Title
JP4256389B2 (ja) テトラペプチドとトリペプチドの混合物を含む組成物
KR100455470B1 (ko) 피토스테롤 조성물의 국소 적용을 통한 포유류 케라틴조직 상태의 조절 방법
JP4007480B2 (ja) スキンケア活性物質の組合せを含有するスキンケア組成物
JP4152987B2 (ja) 哺乳類の発毛の調節
US20030134780A1 (en) Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
CZ20013639A3 (cs) Kosmetický způsob regulace stavu tkáně obsahující keratin
CA2411058C (fr) Traitement cutane a l'aide d'un nouveau retinoide
US20030134781A1 (en) Methods for the treatment of hyperpigmentation of skin
JP2002542179A (ja) スキンケア活性物質の組合せを含有するスキンケア組成物
JP2002080373A (ja) 皮脂の除去のためのある含有量のシクロデキストリンを含む化粧用および皮膚科用製剤
WO1997030690A1 (fr) Traitement de la peau avec des esters de l'acide salicylique
KR20020011988A (ko) 포유류의 케라틴 조직 상태의 조절 방법
EP1310241B1 (fr) Traitement cutané utilisant un rétinoide
CA2428902A1 (fr) Compositions contenant de la consoude officinale et procedes destines a diminuer l'irritation cutanee induite par les retinoides
US20230346677A1 (en) Topical compositions containing vitamin c
US20230346678A1 (en) Topical compositions containing vitamin c
WO2001062247A1 (fr) Compositions topiques contenant des composes thiazolium et methodes d'utilisation correspondantes
AU2002332062A1 (en) Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20221031